ArticleBasic research in cardiology2024
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?
Torsten Christ et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it